Nivolumab Plus Relatlimab vs. Nivolumab Alone for the Adjuvant Treatment of Completely Resected Stage III–IV Melanoma: Primary Results from RELATIVITY-098

Melanoma /

NIVO + RELA did not result in significant RFS improvement vs NIVO alone as adjuvant treatment for stage III–IV melanoma.

Nivolumab Plus Relatlimab vs. Nivolumab Alone for the Adjuvant Treatment of Completely Resected Stage III–IV Melanoma: Primary Results from RELATIVITY-098 Read More »